Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2. Jill Knight jhknight@newsobserver.com
Transgender CEO Martine Rothblatt of United Therapeutics speaks about House Bill 2 and the transgender controversy surrounding North Carolina's House Bill 2. Jill Knight jhknight@newsobserver.com

Editorials

Martine’s message to North Carolina

May 16, 2016 7:13 PM

  Comments  

Videos